bucladesine has been researched along with Pulmonary Edema in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, ML; Chen, HI; Hsu, K; Wang, D; Wu, CP | 1 |
Guo, YL; Gurtner, GH; Kennedy, TP; Sciuto, AM; Strickland, PT | 1 |
Butler, BD; Little, TM | 1 |
Berthiaume, Y | 1 |
Crowley, J; Harada, H; Hatherill, JR; Hoffmann, H; Ishizaka, A; Raffin, TA; Yonemaru, M; Zheng, H | 1 |
Bysani, GK; Gurtner, GH; Hasty, D; Hoidal, JR; Hopkins, C; Kennedy, TP; Lazar, R; Michael, JR; Sciuto, AM; Tolley, E | 1 |
Kratzing, CC; Willis, RJ | 1 |
7 other study(ies) available for bucladesine and Pulmonary Edema
Article | Year |
---|---|
Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP.
Topics: Adrenergic beta-Agonists; Aminophylline; Animals; Blood Pressure; Bucladesine; Capillary Permeability; Cyclic AMP; Disease Models, Animal; Humans; Lung; Lung Injury; Male; Neutrophils; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Edema; Rabbits; Respiratory Distress Syndrome; Terbutaline; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1996 |
Intratracheal administration of DBcAMP attenuates edema formation in phosgene-induced acute lung injury.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Bucladesine; Glutathione; In Vitro Techniques; Injections, Intravenous; Intubation, Intratracheal; Leukotrienes; Male; Malondialdehyde; Organ Size; Phosgene; Proteins; Pulmonary Edema; Rabbits | 1996 |
Dibutyryl cAMP effects on thromboxane and leukotriene production in decompression-induced lung injury.
Topics: Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Bucladesine; Capillary Permeability; Decompression Sickness; Leukocyte Count; Leukotriene E4; Lung; Male; Organ Size; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 1997 |
Effect of exogenous cAMP and aminophylline on alveolar and lung liquid clearance in anesthetized sheep.
Topics: Aminophylline; Animals; Biological Transport, Active; Body Fluids; Bucladesine; Cyclic AMP; Lung; Proteins; Pulmonary Alveoli; Pulmonary Edema; Second Messenger Systems; Sheep | 1991 |
Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs.
Topics: Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Bucladesine; Endotoxins; Escherichia coli; Escherichia coli Infections; Guinea Pigs; Leukocyte Count; Luminescent Measurements; Lung Diseases; Neutrophils; Organ Size; Pentoxifylline; Pulmonary Edema; Serum Albumin | 1991 |
Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene.
Topics: Aminophylline; Animals; Bucladesine; Isoproterenol; Lung; Lung Injury; Malondialdehyde; Phosgene; Pulmonary Edema; Rabbits; Terbutaline | 1989 |
Pulmonary ascorbic acid loss induced by catecholamines.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Ascorbic Acid; Body Weight; Bucladesine; Catecholamines; Epinephrine; Histamine; Isoproterenol; Lung; Male; Mice; Norepinephrine; Organ Size; Phenoxybenzamine; Phenylephrine; Propranolol; Pulmonary Edema; Serotonin | 1974 |